{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-03-06T16%3A00%3A56.577Z&AnswerDate=2018-03-08&publisher.prefLabel=House+of+Commons", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpCreated=2018-03-06T16%3A00%3A56.577Z&AnswerDate=2018-03-08&publisher.prefLabel=House+of+Commons", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-03-06T16%3A00%3A56.577Z&AnswerDate=2018-03-08&publisher.prefLabel=House+of+Commons&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpCreated=2018-03-06T16%3A00%3A56.577Z&AnswerDate=2018-03-08&publisher.prefLabel=House+of+Commons", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-03-06T16%3A00%3A56.577Z&AnswerDate=2018-03-08&publisher.prefLabel=House+of+Commons", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-03-06T16%3A00%3A56.577Z&AnswerDate=2018-03-08&publisher.prefLabel=House+of+Commons", "items" : [{"_about" : "http://data.parliament.uk/resources/855893", "AnsweringBody" : [{"_value" : "Church Commissioners"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/855893/answer", "answerText" : {"_value" : "
The Church of the Holy Sepulchre has reopened following three days of closure which left pilgrims and visitors praying in the square outside. The dispute was over a new tax policy and proposed land expropriation law.<\/p>
Officials from Church House and staff at Lambeth Palace were in regular contact with the Heads of Churches Group in the City of Jerusalem through Archbishop Suheil the Anglican Archbishop of Jerusalem as the events unfolded. On the 5th<\/sup> of March, the Archbishop of Canterbury and the Cardinal Archbishop of Westminster wrote a joint letter to the Israeli Ambassador in the UK, to say that both Churches believed \u201cthe measures being pressed in Jerusalem and in the Knesset, were a clear and evident threat to the status quo and that this risked undermining prospects for peaceful coexistence between communities, at a time of already heightened tensions.\u201d Specifically, that, \u201cthe new policy would cause serious damage to the Christian presence in Jerusalem, to Christian families, and to the Christian institutions, including hospitals and schools, which serve many of the poorest people, regardless of their background.\u201d<\/p> The Church of England and the Roman Catholic Bishops Conference in England and Wales will continue to work closely together on issues relating to Israel and Palestine. Bishops from around the world make an annual joint visit to the Holy Land as part of the Holy Land Coordination Group. The Bishop of Southwark along with the Catholic Bishops will be hosting a meeting for all Members on the 15th<\/sup> May, 3-4pm in Committee Room 2A to discuss and feedback the findings of their visit.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/312", "label" : {"_value" : "Biography information for Dame Caroline Spelman"}
}
, "answeringMemberConstituency" : {"_value" : "Meriden"}
, "answeringMemberPrinted" : {"_value" : "Dame Caroline Spelman"}
, "dateOfAnswer" : {"_value" : "2018-03-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-08T15:02:00.343Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "9"}
, "answeringDeptShortName" : {"_value" : "Church Commissioners"}
, "answeringDeptSortName" : {"_value" : "Church Commissioners"}
, "date" : {"_value" : "2018-03-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Churches: Jerusalem"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the right hon. Member for Meriden, representing the Church Commissioners, what discussions the Church of England has had with the leaders of other Christian Churches on the closure of the Church of the Holy Sepulchre in Jerusalem.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4635", "label" : {"_value" : "Biography information for Eddie Hughes"}
}
, "tablingMemberConstituency" : {"_value" : "Walsall North"}
, "tablingMemberPrinted" : [{"_value" : "Eddie Hughes"}
], "uin" : "904236"}
, {"_about" : "http://data.parliament.uk/resources/855487", "AnsweringBody" : [{"_value" : "Department for Digital, Culture, Media and Sport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/855487/answer", "answerText" : {"_value" : " DCMS does not centrally collect the specific data requested.<\/p> <\/p> Information regarding contracts above the value of £10,000 is published on Contracts Finder on GOV.UK, available at https://www.gov.uk/contracts-finder.<\/p> <\/p> The Interception of Communications Commissioner and the Information Commissioner\u2019s Office also have responsibilities in this area.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4115", "label" : {"_value" : "Biography information for Margot James"}
}
, "answeringMemberConstituency" : {"_value" : "Stourbridge"}
, "answeringMemberPrinted" : {"_value" : "Margot James"}
, "dateOfAnswer" : {"_value" : "2018-03-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-08T11:43:44.617Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "10"}
, "answeringDeptShortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "answeringDeptSortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "date" : {"_value" : "2018-03-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Department for Digital, Culture, Media and Sport: Internet"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Digital, Culture, Media and Sport, what estimate he has made of the volume of UK citizens\u2019 data held by companies (a) supplying cloud services to his department and (b) contracted to deliver cloud services on behalf of his Department that is subject to information requests from US Government bodies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/261", "label" : {"_value" : "Biography information for James Gray"}
}
, "tablingMemberConstituency" : {"_value" : "North Wiltshire"}
, "tablingMemberPrinted" : [{"_value" : "James Gray"}
], "uin" : "130794"}
, {"_about" : "http://data.parliament.uk/resources/855490", "AnsweringBody" : [{"_value" : "Home Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/855490/answer", "answerText" : {"_value" : " I welcome the National Police Chiefs\u2019 Council\u2019s and Association of Police and Crime Commissioner\u2019s swift action to minimise the impact on the criminal justice system and protect evidence for live cases. The contractual arrangements are a commercial matter for the police and the company.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1561", "label" : {"_value" : "Biography information for Mr Nick Hurd"}
}
, "answeringMemberConstituency" : {"_value" : "Ruislip, Northwood and Pinner"}
, "answeringMemberPrinted" : {"_value" : "Mr Nick Hurd"}
, "dateOfAnswer" : {"_value" : "2018-03-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-08T17:45:34.453Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "1"}
, "answeringDeptShortName" : {"_value" : "Home Office"}
, "answeringDeptSortName" : {"_value" : "Home Office"}
, "date" : {"_value" : "2018-03-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Key Forensic Services: Insolvency"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for the Home Department, pursuant to the Answer of 26 February 2018 to Question 128775, on Key Forensic Services: Insolvency, which police forces were contracted with Key Forensic Services prior to that company entering administration.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4473", "label" : {"_value" : "Biography information for Louise Haigh"}
}
, "tablingMemberConstituency" : {"_value" : "Sheffield, Heeley"}
, "tablingMemberPrinted" : [{"_value" : "Louise Haigh"}
], "uin" : "130797"}
, {"_about" : "http://data.parliament.uk/resources/855493", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/855493/answer", "answerText" : {"_value" : " The information requested is shown in the table below.<\/p> <\/p> Number of Employment and Support Allowance (ESA) claimants with at least one work capability assessment outcome, with a main disabling condition of Cystic Fibrosis, Motor Neurone Disease, Multiple Sclerosis, Parkinson\u2019s Disease or Rheumatoid Arthritis, by assessment type, assessment outcome and year 20082<\/sup> to 20174<\/sup>, Great Britain<\/strong><\/p> <\/strong><\/p><\/td> <\/strong><\/p><\/td> \u2018000s<\/em><\/strong><\/p><\/td><\/tr> Condition<\/strong><\/p><\/td> Year of completed assessment<\/strong><\/p><\/td><\/tr> Assessment type - Outcome<\/p><\/td> 08<\/strong><\/p><\/td> 09<\/strong><\/p><\/td> 10<\/strong><\/p><\/td> 11<\/strong><\/p><\/td> 12<\/strong><\/p><\/td> 13<\/strong><\/p><\/td> 14<\/strong><\/p><\/td> 15<\/strong><\/p><\/td> 16<\/strong><\/p><\/td> 17<\/strong><\/p><\/td> Total<\/strong><\/p><\/td><\/tr> Cystic Fibrosis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 1.0<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.6<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.6<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Motor Neurone Disease<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 1.5<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.2<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Multiple Sclerosis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.5<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 1.5<\/p><\/td> 1.3<\/p><\/td> 1.8<\/p><\/td> 1.5<\/p><\/td> 1.1<\/p><\/td> 0.7<\/p><\/td> 9.7<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 2.8<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.4<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 2.2<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.8<\/p><\/td> 2<\/p><\/td> 2<\/p><\/td> 1.8<\/p><\/td> 0.4<\/p><\/td> 3.7<\/p><\/td> 1.1<\/p><\/td> 9.7<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.6<\/p><\/td> 0.7<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 1.7<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.5<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 1.4<\/p><\/td> 4.2<\/p><\/td> 7<\/p><\/td> 2.3<\/p><\/td> 0.7<\/p><\/td> 0.5<\/p><\/td> 0.1<\/p><\/td> 16.2<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.5<\/p><\/td> 1.1<\/p><\/td> 0.9<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 2.6<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> Parkinsons Disease<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.4<\/p><\/td> 0.4<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 2.1<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.8<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.8<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.4<\/p><\/td> 0.1<\/p><\/td> 1.3<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.2<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 1.3<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Rheumatoid Arthritis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 1.0<\/p><\/td> 0.9<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 4.5<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 3.7<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.8<\/p><\/td> 0.9<\/p><\/td> 0.6<\/p><\/td> 0.7<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 0.3<\/p><\/td> 5.2<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.8<\/p><\/td> 1.4<\/p><\/td> 1.5<\/p><\/td> 0.4<\/p><\/td> 1.9<\/p><\/td> 0.8<\/p><\/td> 5.9<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.8<\/p><\/td> 1.2<\/p><\/td> 0.8<\/p><\/td> 0.4<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 3<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.4<\/p><\/td> 0.2<\/p><\/td> 1.7<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.5<\/p><\/td> 1.5<\/p><\/td> 2.6<\/p><\/td> 1.1<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 6.6<\/strong><\/p><\/td><\/tr>